Skip to content


BMC Infectious Diseases

Open Access

Serological and molecular diagnosis of hepatitis B virus

BMC Infectious Diseases201212(Suppl 1):P31

Published: 4 May 2012


Positive CaseResource Limited SettingSuspected CaseMolecular DetectionMolecular Assay


Hepatitis B is a potentially life threatening liver infection which leads to millions of deaths annually. Serological and molecular assays for hepatitis B virus are the major diagnostic tools. Dried blood spot (DBS), a minimally invasive procedure, is an alternative to serum and can be used for field based studies for molecular detection. The present aim of this study is to diagnose HBV infection by combination of serological and molecular methods from serum and dried blood spot.


Blood was collected from suspected cases of liver diseases attending JIPMER Hospital, during September 2010 to October 2011. The study group is divided into two each having 30 cases of hepatitis B surface marker positive and negative profile respectively. Samples were analyzed for complete serological tests (surface and core antigen) and PCR were performed on serum samples and DBS.


Out of 30 HBsAg positive cases screened by ELISA, 22 samples were found positive of HBV DNA by PCR method from serum, which includes 2 samples with only surface (HBsAg) and antibody to core antigen (IgM anti HBc) positive. All these 22 positive cases were also been detected from DBS after storing the sample at 25°C for 4 and 7 days.


It is important to detect both serological and molecular markers to diagnose hepatitis B for appropriate management of disease Since dried blood spot yields comparable results to serum in detecting HBV DNA it can be used as convenient method of collecting samples than venous blood, particularly in resource limited settings.

Authors’ Affiliations

Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India


© Durgadevi et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.